As shown in Figure 4A, MetS was associated with an upregulation in the mRNA levels of the proinflammatory markers TNF-α (p < 0.01), IL-1β (p < 0.05), IL-6 (p < 0.05), and MCP-1 (p < 0.05). This evidence concerns the gene CCL2 and metabolic syndrome.